carbidopa has been researched along with Cholera Infantum in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpintero, P; de Deus, T; de la Fuente-Fernandez, R; Echarri-Piudo, A; Llaneza-Gonzalez, MA; Lopez-Pazos, E; Macias-Arribi, M; Santos-Garcia, D | 1 |
Fung, VS; Herawati, L; Wan, Y | 1 |
Calle, AP; Diez, MJ; Fernández, N; García, JJ; Sahagún, A; Sierra, M | 1 |
Bömelburg, M; Ebersbach, G; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T | 1 |
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF | 1 |
Pfeiffer, R | 1 |
Miller, EM; Wiener, L | 1 |
2 review(s) available for carbidopa and Cholera Infantum
Article | Year |
---|---|
[Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].
Topics: Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Duodenum; Gastrointestinal Diseases; Gastrostomy; Granuloma; Humans; Infusion Pumps; Infusions, Parenteral; Levodopa; Multicenter Studies as Topic; Observational Studies as Topic; Pain; Parkinson Disease; Peritonitis; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Surgical Stomas | 2014 |
Optimization of levodopa therapy.
Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders | 1992 |
2 trial(s) available for carbidopa and Cholera Infantum
Article | Year |
---|---|
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome | 2009 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index | 1997 |
4 other study(ies) available for carbidopa and Cholera Infantum
Article | Year |
---|---|
Effects of Plantago ovata husk on levodopa (with Carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders.
Topics: Animals; Autonomic Nervous System; Biological Availability; Carbidopa; Gastrointestinal Diseases; Levodopa; Plantago; Rabbits | 2009 |
Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease | 2012 |
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2005 |
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia Diseases; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1974 |